FDA Grants Approval for I-Flow Kit
I-Flow Corp. said Tuesday it received approval from the U.S. Food and Drug Administration to market its disposable PainBuster infusion pain management kit for orthopedic surgery patients.
I-Flow said the system uses Bupivacaine HC1, a nonnarcotic drug, avoiding the side effects of narcotics like morphine. The drug is infused directly into a patient 24 to 48 hours after an operation,
The Lake Forest company’s stock climbed 13%, or 25 cents, to $2.13 a share.
I-Flow designs medical infusion systems for inpatient and outpatient care.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.